You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
SBC: ARTANN LABORATORIES, INC. Topic: N/ADESCRIPTION (provided by applicant): Pelvic organ prolapse is a highly prevalent condition affecting at least 50% of women in the US during their lifetimes. Some loss of utero-vaginal support occurs in most adult women, however, the true etiology of prolapse and differences seen among individuals is not entirely understood. Changes in the elasticity of the vaginal walls, connective support tissues ...
SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health -
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
SBC: ARTANN LABORATORIES, INC. Topic: NIADESCRIPTION (provided by applicant): Pelvic organ prolapse is a highly prevalent condition affecting at least 50% of women in the US during their lifetimes. Some loss of utero-vaginal support occurs in most adult women; however, the true etiology of prolapse and differences seen among individuals is not entirely understood. Changes in the elasticity of the vaginal walls, connective support tissues ...
SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
SBC: ARTANN LABORATORIES, INC. Topic: NIADESCRIPTION (provided by applicant): Pelvic organ prolapse is a highly prevalent condition affecting at least 50% of women in the US during their lifetimes. Some loss of utero-vaginal support occurs in most adult women, however, the true etiology of prolapse and differences seen among individuals is not entirely understood. Changes in the elasticity of the vaginal walls, connective support tissues ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
SBC: ARTANN LABORATORIES, INC. Topic: NPelvic organ prolapse POP is a highly prevalent condition affecting over of women in the US during their lifetimes Urinary incontinence UI affects an estimated of women Both POP and UI are more common in women than in men and their prevalence is increased with age Some loss of utero vaginal support occurs in most adult women however the true etiology of prolapse and differences se ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
SBC: ARTANN LABORATORIES, INC. Topic: NPelvic organ prolapse POP is a highly prevalent condition affecting over of women in the US during their lifetimes Urinary incontinence UI affects an estimated of women Both POP and UI are more common in women than in men and their prevalence is increased with age Some loss of utero vaginal support occurs in most adult women however the true etiology of prolapse and differences se ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
SBC: ORGANIX CHEMISTRY SOLUTIONS LLC Topic: NIDADESCRIPTION (provided by applicant): Chronic pain can result from various disease conditions and about 45% of the U. S. population seeks medical help for treatment of pain. Neuropathic pain is a type of chronic pain which is very difficult to treat, and most patients do not get adequate relief. A promising therapeutic drug target for the treatment of inflammation and pain is the cannabinoid CB2 re ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
VAGINAL VACCINATION WITH HERPES TYPE-2 PROTEIN AND DNA
SBC: PROTEIN EXPRESS, INC. Topic: N/ANot Available Physical Optics Corporation (POC) proposes to design and develop a new single curvature collimating display screen (CDS) for out-the-window simulator applications. This proposed screen is based on a unique combination of two technologies: a holographic light shaping diffuser (LDStm) with predetermined diffusion properties, integratd with a microlens array. This proposed screen will ...
SBIR Phase I 1999 Department of Health and Human Services -
Vagus Nerve Stimulation Treatment for Asthmatic Bronchoconstriction
SBC: ROSELLINI SCIENTIFIC, LLC Topic: NHLBIProject Summary The Specific Aim of this proposal is to test the feasibility of using vagus nerve stimulation VNS for treating asthma related airway constriction that is refractory to current treatments There are approximately million people with asthma in the US About percent of these asthma sufferers experience early and late phase severe asthmatic bronchoconstriction that is refract ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
VAL-0914 Decreases PAO to Protect Against Cardiac Proteinopathies
SBC: Enable Therapeutics LLC Topic: NHLBIPROJECT SUMMARY Soluble pre-amyloid oligomers (PAO) are the most potent mediators of cytotoxicity, despite common focus on autophagy as a means to clear larger misfolded protein aggregates. Specifically, PAO, rather than aggresomes, are most correlated with desmin-related cardiomyopathy (DRC) caused by an Arg120Gly missense mutation of αB-Crystallin (CryABR120G). In addition to causing DRC, emerg ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Valens: A Mass Spectrometry-Based Antibody Sequencing Tool by Digital Proteomics
SBC: ABTERRA BIOSCIENCES, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Monoclonal antibodies exhibit high specificity for target molecules and for that reason have been successfully utilized as therapeutic and diagnostic agents. The sequence of amino acids comprising the primary structureof an antibody is largely responsible for its binding preference and efficacy. Therefore, antibody sequencing is a central requirement for the de ...
SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health